The pharmaceutical giant behind the sensational drug Ozempic is racing to bring a pill to the market, which would be cheaper and easier to take.Ozempic, Wegovy and Mounjaro are brand names for similar injectable drugs that have sky rocketed in popularity, and which enable weight loss by reducing appetite.Now, companies , Eli Lilly and Novo Nordisk are looking to cash in on the craze by deploying the main ingredient, semaglutide, in pill form. Analysts have said the market for such an oral drug could be worth $100billion by the end of the decade.
Load More
Load More